Comparison of glioblastoma (GBM) molecular classification methods

E Lee, RL Yong, P Paddison, J Zhu - Seminars in cancer biology, 2018 - Elsevier
Glioblastoma (GBM) is the most aggressive and common form of brain cancer in adults.
GBM is characterized by poor survival and remarkably high tumors heterogeneity (both …

Tissue factor is a critical regulator of radiation therapy-induced glioblastoma remodeling

HM Jeon, JY Kim, HJ Cho, WJ Lee, D Nguyen, SS Kim… - Cancer cell, 2023 - cell.com
Radiation therapy (RT) provides therapeutic benefits for patients with glioblastoma (GBM),
but inevitably induces poorly understood global changes in GBM and its microenvironment …

Target-based anticancer indole derivatives for the development of anti-glioblastoma agents

S Salerno, E Barresi, E Baglini, V Poggetti… - Molecules, 2023 - mdpi.com
Glioblastoma (GBM) is the most aggressive and frequent primary brain tumor, with a poor
prognosis and the highest mortality rate. Currently, GBM therapy consists of surgical …

The mitotic kinesin KIF11 is a driver of invasion, proliferation, and self-renewal in glioblastoma

M Venere, C Horbinski, JF Crish, X Jin… - Science translational …, 2015 - science.org
The proliferative and invasive nature of malignant cancers drives lethality. In glioblastoma,
these two processes are presumed mutually exclusive and hence termed “go or grow.” We …

Genome-wide CRISPR-Cas9 screens reveal loss of redundancy between PKMYT1 and WEE1 in glioblastoma stem-like cells

CM Toledo, Y Ding, P Hoellerbauer, RJ Davis… - Cell reports, 2015 - cell.com
To identify therapeutic targets for glioblastoma (GBM), we performed genome-wide CRISPR-
Cas9 knockout (KO) screens in patient-derived GBM stem-like cells (GSCs) and human …

BUB1 drives the occurrence and development of bladder cancer by mediating the STAT3 signaling pathway

N Jiang, Y Liao, M Wang, Y Wang, K Wang… - Journal of Experimental …, 2021 - Springer
Background The incidence of bladder urothelial carcinoma (UC), a common malignancy of
the urinary tract, is approximately three times higher in men than in women. High expression …

BUB1B and circBUB1B_544aa aggravate multiple myeloma malignancy through evoking chromosomal instability

X Tang, M Guo, P Ding, Z Deng, M Ke, Y Yuan… - … and Targeted Therapy, 2021 - nature.com
Multiple myeloma (MM) is an incurable plasma cell malignancy in the bone marrow
characterized by chromosome instability (CIN), which contributes to the acquisition of …

[HTML][HTML] ZFHX4 interacts with the NuRD core member CHD4 and regulates the glioblastoma tumor-initiating cell state

Y Chudnovsky, D Kim, S Zheng, WA Whyte, M Bansal… - Cell reports, 2014 - cell.com
Glioblastoma (GBM) harbors subpopulations of therapy-resistant tumor-initiating cells (TICs)
that are self-renewing and multipotent. To understand the regulation of the TIC state, we …

Efficient CRISPR/Cas9-assisted gene targeting enables rapid and precise genetic manipulation of mammalian neural stem cells

RB Bressan, PS Dewari, M Kalantzaki… - …, 2017 - journals.biologists.com
Mammalian neural stem cell (NSC) lines provide a tractable model for discovery across stem
cell and developmental biology, regenerative medicine and neuroscience. They can be …

Supramolecularly enabled pH-triggered drug action at tumor microenvironment potentiates nanomedicine efficacy against glioblastoma

S Quader, X Liu, K Toh, YL Su, AR Maity, A Tao… - Biomaterials, 2021 - Elsevier
The crucial balance of stability in blood-circulation and tumor-specific delivery has been
suggested as one of the challenges for effective bench-to-bedside translation of …